0.000USD0.000Pre-market 08/03, 09:30 (ET)
601.99MMarket Cap
19.87P/E TTM
Key Figures
4.170Open
4.210High
2.99MVolume
19.87P/E TTM
36.22P/E Dynamic
--Dividend TTM
2.01%Turnover Ratio
4.270Prev. Close
3.973Low
7.76MTurnover
14.50P/E Static
2.53P/B
0.00%Div Yield TTM
10.60%ROA
7.99052wk High
1.17Volume Ratio
42.42MNet Profit
148.93MShares
0.2078EPS TTM
1.47Beta
13.77%ROE
3.02552wk Low
5.56%Amplitude
68.50%Gross Margin
601.99MMarket Cap
2.00Reward/Risk
2.46%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
MiMedx Group Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 77 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 6.60.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
MiMedx Group Inc's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
MiMedx Group Inc Highlights
StrengthsRisks
MiMedx Group Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
MiMedx Group Inc Info
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
Ticker SymbolMDXG
CompanyMiMedx Group Inc
CEOCapper (Joseph H)
Websitehttps://mimedx.com/
Shareholders
FAQs
What is the current price of MiMedx Group Inc (MDXG)?
The current price of MiMedx Group Inc (MDXG) is 4.13.
What is the symbol of MiMedx Group Inc?
The ticker symbol of MiMedx Group Inc is MDXG.
What is the 52-week high of MiMedx Group Inc?
The 52-week high of MiMedx Group Inc is 7.99.
What is the 52-week low of MiMedx Group Inc?
The 52-week low of MiMedx Group Inc is 3.02.
What is the market capitalization of MiMedx Group Inc?
The market capitalization of MiMedx Group Inc is 601.99M.
Is MiMedx Group Inc (MDXG) currently rated as Buy, Hold, or Sell?
According to analysts, MiMedx Group Inc (MDXG) has an overall rating of Buy, with a price target of 6.60.
What is the Earnings Per Share (EPS TTM) of MiMedx Group Inc (MDXG)?
The Earnings Per Share (EPS TTM) of MiMedx Group Inc (MDXG) is 0.33.